Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D; pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;
elironrasib (RMC-6291),a RAS(ON) G12C-selective inhibitor;
zoldonrasib (RMC-9805),a RAS(ON) G12D-selective inhibitor;
and RMC-5127, a RAS(ON)G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity
The Area Business Lead is responsible for the team promoting Revolution Medicines products/services to the oncology community in the North-Center area of Spain and responsible for implementing sales strategy in the area. This person is ultimately accountable for building, leading, inspiring, developing and guiding the activities of 7 Senior Oncology

📌 Area Business Lead, Spain (Madrid)
🏢 Revolution Medicines
📍 Madrid